Cargando…
Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
INTRODUCTION: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. METHODS: A systematic review of the English-langu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675727/ https://www.ncbi.nlm.nih.gov/pubmed/26253854 http://dx.doi.org/10.1007/s40123-015-0037-z |
_version_ | 1782405049401475072 |
---|---|
author | Thomas, Merina Vajaranant, Thasarat S. Aref, Ahmad A. |
author_facet | Thomas, Merina Vajaranant, Thasarat S. Aref, Ahmad A. |
author_sort | Thomas, Merina |
collection | PubMed |
description | INTRODUCTION: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. METHODS: A systematic review of the English-language literature was conducted by performing a broad search of PubMed from 1972 through 2015 using the keywords hypotony maculopathy and hypotony. Additional articles were identified from bibliographies of relevant articles. RESULTS: Hypotony maculopathy was infrequent before the introduction of antimetabolite agents in glaucoma-filtering surgery, and the incidence of this entity is now up to 20%. Risk factors for developing hypotony maculopathy include male gender, young age, myopia, and primary filtering surgery. Correctly identifying the etiology of hypotony is essential for successful treatment. Treatment of hypotony maculopathy includes procedures to elevate the intraocular pressure, thus reversing the collapse of the scleral wall and chorioretinal wrinkling. CONCLUSION: This review discusses the definition, clinical presentation, pathophysiology, incidence and risk factors, prevention and treatment of hypotony maculopathy. |
format | Online Article Text |
id | pubmed-4675727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-46757272015-12-18 Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods Thomas, Merina Vajaranant, Thasarat S. Aref, Ahmad A. Ophthalmol Ther Review INTRODUCTION: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. METHODS: A systematic review of the English-language literature was conducted by performing a broad search of PubMed from 1972 through 2015 using the keywords hypotony maculopathy and hypotony. Additional articles were identified from bibliographies of relevant articles. RESULTS: Hypotony maculopathy was infrequent before the introduction of antimetabolite agents in glaucoma-filtering surgery, and the incidence of this entity is now up to 20%. Risk factors for developing hypotony maculopathy include male gender, young age, myopia, and primary filtering surgery. Correctly identifying the etiology of hypotony is essential for successful treatment. Treatment of hypotony maculopathy includes procedures to elevate the intraocular pressure, thus reversing the collapse of the scleral wall and chorioretinal wrinkling. CONCLUSION: This review discusses the definition, clinical presentation, pathophysiology, incidence and risk factors, prevention and treatment of hypotony maculopathy. Springer Healthcare 2015-08-08 2015-12 /pmc/articles/PMC4675727/ /pubmed/26253854 http://dx.doi.org/10.1007/s40123-015-0037-z Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Thomas, Merina Vajaranant, Thasarat S. Aref, Ahmad A. Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods |
title | Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods |
title_full | Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods |
title_fullStr | Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods |
title_full_unstemmed | Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods |
title_short | Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods |
title_sort | hypotony maculopathy: clinical presentation and therapeutic methods |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675727/ https://www.ncbi.nlm.nih.gov/pubmed/26253854 http://dx.doi.org/10.1007/s40123-015-0037-z |
work_keys_str_mv | AT thomasmerina hypotonymaculopathyclinicalpresentationandtherapeuticmethods AT vajaranantthasarats hypotonymaculopathyclinicalpresentationandtherapeuticmethods AT arefahmada hypotonymaculopathyclinicalpresentationandtherapeuticmethods |